Effect of dulaglutide in promoting abstinence during smoking cessation: 12-month follow-up of a single-centre, randomised, double-blind, placebo-controlled, parallel group trial.
Lüthi H, Lengsfeld S, Burkard T, Meienberg A, Jeanloz N, Vukajlovic T, Bologna K, Steinmetz M, Bathelt C, Sailer CO, Laager M, Vogt DR, Hemkens LG, Speich B, Urwyler SA, Kühne J, Baur F, Lutz LN, Erlanger TE, Christ-Crain M, Winzeler B.
Lüthi H, et al. Among authors: christ crain m.
EClinicalMedicine. 2024 Feb 9;68:102429. doi: 10.1016/j.eclinm.2024.102429. eCollection 2024 Feb.
EClinicalMedicine. 2024.
PMID: 38371479
Free PMC article.
Herein we report long-term abstinence rates and weight developments after 24 and 52 weeks. ...No treatment-related serious adverse events or deaths occurred. INTERPRETATION: Dulaglutide does not improve long-term smoking abstinence, but has potential to counteract w …
Herein we report long-term abstinence rates and weight developments after 24 and 52 weeks. ...No treatment-related serious adverse ev …